Circulating lipocalin‐2 as a novel biomarker for early neurological deterioration and unfavorable prognosis after acute ischemic stroke

INTRODUCTION: Lipocalin‐2 (LCN2) is an acute‐phase protein that could mediate neuroinflammation after brain injury. We aimed to evaluate if LCN2 level was associated with early neurological deterioration (END) in acute ischemic stroke patients, thus hindering clinical recovery. METHODS: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yi, Zhuo, Xingfeng, Xing, Kai, Huang, Zhenqian, Guo, Hongquan, Gong, Pengyu, Zhang, Xiaohao, Li, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176013/
https://www.ncbi.nlm.nih.gov/pubmed/36974345
http://dx.doi.org/10.1002/brb3.2979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176013/
https://www.ncbi.nlm.nih.gov/pubmed/36974345
http://dx.doi.org/10.1002/brb3.2979

Ejemplares similares